Because an alcohol use disorder can be a chronic relapsing disease, persistence is key. It is rare that someone would go to treatment once and then never drink again. More often, people must repeatedly try to quit or cut back, experience recurrences, learn from them, and then keep trying. For many, continued followup with a treatment provider is critical to overcoming problem drinking.
Where alcoholics are concerned, their brains have become so accustomed to dealing with alcohol that the volume of chemicals being produced to overcome the effects of alcohol is excessive. As blood alcohol levels start to fall, those same brain chemicals start causing unpleasant withdrawal symptoms. The only two solutions are to either consume more alcohol or wait it out until the body readjusts.
The Benchmark Recovery Center, formerly known as the Mark Houston Recovery Center, bases their treatment program on a 90-day, 12-step program. Part of the program includes life skills and a fitness program. The Center recognizes that every patient has unique needs to achieve recovery, so it avoids the one-size-fits-all approach to treatment. The Center consists of two separate facilities for men and women; it can provide for 58 patients at a time and currently claims a 74% success rate.
Tobacco: Nicotine replacement therapies have several forms, including the patch, spray, gum, and lozenges. These products are available over the counter. The U.S. Food and Drug Administration (FDA) has approved two prescription medications for nicotine addiction: bupropion (Zyban®) and varenicline (Chantix®). They work differently in the brain, but both help prevent relapse in people trying to quit. The medications are more effective when combined with behavioral treatments, such as group and individual therapy as well as telephone quitlines.
Certain opioid medications such as methadone and more recently buprenorphine (In America, "Subutex" and "Suboxone") are widely used to treat addiction and dependence on other opioids such as heroin, morphine or oxycodone. Methadone and buprenorphine are maintenance therapies intended to reduce cravings for opiates, thereby reducing illegal drug use, and the risks associated with it, such as disease, arrest, incarceration, and death, in line with the philosophy of harm reduction. Both drugs may be used as maintenance medications (taken for an indefinite period of time), or used as detoxification aids. All available studies collected in the 2005 Australian National Evaluation of Pharmacotherapies for Opioid Dependence suggest that maintenance treatment is preferable, with very high rates (79–100%) of relapse within three months of detoxification from LAAM, buprenorphine, and methadone.
Behavioral Health of the Palm Beaches (BHPB) is a comprehensive treatment center that provides mental health and trauma programs in addition to their reputable addiction program. BHPB was founded in 1997 by Dr. Donald Mullaney, a recovering addict. BHPB has some of the most talented treatment professionals in the nation who help outline specialized treatment plans for each patient. Treatment lasts a minimum of 30 days, but long-term care lasting up to 12 months is available.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)